Drug Channels

FEBRUARY 23, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She outlines four success factors for manufacturers that use a digital hub partner. To learn more, register for Phil's upcoming webinar: Improving Access, Coverage, and GTN with a Digital Hub. Read on for Nicole’s insights.

Drugs 84

Drugs 84

SCIENMAG: Medicine & Health

AUGUST 21, 2023

FROM: James Urton Credit: NASA/MODIS Rapid Response Team/Goddard Space Flight Center FROM: James Urton University of Washington 206-543-2580 jurton@uw.edu (Note: researcher contact information at the end) For Immediate Release August 21, 2023 In 2006, the Tripod Complex Fire burned more than 175,000 acres in north-central Washington.

Research 87

Research Science 87

Drug Channels

MARCH 28, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. All rights reserved.

Marketing 81

Marketing Science Therapies Production 81

Drug Channels

FEBRUARY 10, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Lauren will also be exploring hub launch excellence at Informa Connect’s Hub and Specialty Pharmacy Models East conference on March 20-22. Read on for Lauren’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 96

Specialty Pharmacies Pharmacy Drugs 96

Drug Channels

MAY 7, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The companies face renewed scrutiny from the Federal Trade Commission, the Office of Inspector General, and members of Congress. All rights reserved. This Feed is for personal non-commercial use only.

Specialty Pharmacies 90

Specialty Pharmacies Pharmacy Drugs 90

Drug Channels

FEBRUARY 7, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Sadly, pharma industry perma-critics refuse to accept that brand-name drug prices are falling —or that prescription drug spending is a small and stable portion of overall U.S. healthcare expenditures. All rights reserved.

Pharmaceutical Companies 93

Pharmaceutical Companies Drugs Pharmaceuticals Trials 93

Drug Channels

JANUARY 17, 2023

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. If this clip whets your appetite for more, purchase a replay of the full 90 minute Drug Channels Outlook 2023 video webinar. Or register for my forthcoming 2023 video webinar series. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Drugs 97

Drug Channels

MAY 2, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, join Chris on May 21 at 1:00 p.m. ET for a free online panel discussion about how brands can continue to offer robust patient support despite IRA challenges. Read on for Chris’ insights. All rights reserved.

Marketing 86

Marketing Drugs 86

Drug Channels

FEBRUARY 4, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. To learn more about Medicare copayments and how the RE Assist solution helps patients, register to view Real Endpoints’ free webcast: Solving the Medicare Co-pay Dilemma. Read on for Jeff’s insights. d/b/a Drug Channels Institute.

Disease 92

Disease Drugs 92

Drug Channels

FEBRUARY 21, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Want to learn more? Join me on April 5 for DCI's next live webinar: Drug Channel Implications of the Inflation Reduction Act. Official announcement coming soon! All rights reserved. This Feed is for personal non-commercial use only.

Biosimilars 98

Biosimilars Drugs Government Production 98

Drug Channels

JANUARY 13, 2023

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. He describes CoverMyMeds’ provider alerts solution, which is designed to minimize medication errors. Click here to learn more about CoverMyMeds’ Provider Medication Alerts solution. Read on for Clay’s insights. d/b/a Drug Channels Institute.

Therapies 87

Therapies Production Drugs 87

Drug Channels

OCTOBER 13, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. These organizations are poised to exert greater control over patient access, sites of care/dispensing, and pricing. But as I note below, Federal Trade Commission chair Lina M. Khan has other ideas about these companies. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

JULY 15, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Carolyn explains the advantages of alternative payment models (APM) for measuring and rewarding value and outcomes in our healthcare system. For more on how APMs measure value, click here to learn about MMIT’s Pulse Analytics Solution. Read on for Carolyn’s insights.

Drugs 87

Drugs 87

Drug Channels

OCTOBER 20, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Melanie explains how such fulfillment tools also increase a pharmacy’s revenues and lowers its costs. Click here to learn about CoverMyMeds’ automated central fill solutions. Read on for Melanie’s insights. d/b/a Drug Channels Institute.

Pharmacy 91

Pharmacy Treatment Production Drugs 91

Drug Channels

FEBRUARY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. As he explains, manufacturers want hub partners that can take a holistic approach and address each patient’s individual needs. Nasir also discusses how hub selection criteria are evolving. Read on for Nasir’s insights. All rights reserved.

Production 79

Production Research Drugs 79

Drug Channels

JUNE 6, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Full salary data below for your enjoyment or sorrow. As expected, the past few years have been highly challenging for retail-employed pharmacists. Expect further declines as the shakeout continues. d/b/a Drug Channels Institute. This Feed is for personal non-commercial use only.

Pharmacy 96

Pharmacy Hospitals Marketing Drugs 96

Drug Channels

NOVEMBER 11, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about AmerisourceBergen’s Cell and Gene Therapy solutions for biopharma companies, providers, and patients. Read on for Lung-I’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Therapies 88

Therapies Drugs 88

Drug Channels

FEBRUARY 17, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Jim discusses GoodRx Assist , a point-of-sale (POS) rebate program designed to help cash-paying patients start and stay on brand-name medication. Click here to learn more about GoodRx Assist. Read on for Jim’s insights. d/b/a Drug Channels Institute.

Drugs 86

Drugs 86

Drug Channels

SEPTEMBER 22, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. To learn about CoverMyMeds’ medication affordability solutions that engage patients, download the CoverMyMeds white paper: Overcoming Affordability Challenges with Patient-Centered Solutions. Read on for Kristina’s insights. d/b/a Drug Channels Institute.

Pharmacy 91

Pharmacy Production Drugs 91

Drug Channels

MAY 14, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Chalk off these coinsurance surprises to yet another unintended consequence of the IRA. Seniors who are expecting to see costs drop may find they are instead being taken for a rollercoaster ride. All rights reserved.

Drugs 86

Drugs 86

Drug Channels

JUNE 16, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. He then discusses Advanced Gateway, a technology that integrates patient, provider, and manufacturer services. Click here to learn more about how AssistRx’s Advanced Gateway can impact patient support programs. Read on for Derek’s insights. d/b/a Drug Channels Institute.

Engineering 87

Engineering Drugs 87

Drug Channels

DECEMBER 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. She describes how CoverMyMeds improves the patient experience by blending technology with human expertise and connection. Click here to learn about CoverMyMed’s next-generation patient support services. Read on for Kelly’s insights. d/b/a Drug Channels Institute.

Therapies 87

Therapies Production Drugs 87

Drug Channels

JUNE 2, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. To learn more, download the Wolters Kluwer free ebook: Drug Data Unity: Realistic and Idealistic Futures for Information Exchange. Read on for Bonnie’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmaceuticals 87

Pharmaceuticals Drugs 87

Drug Channels

FEBRUARY 24, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Matt shares three key findings from CareMetx’s exclusive new survey on patient support services for specialty pharmaceuticals. To learn more, download CareMetx’s free 2022 Report - Patient Services Trends. Read on for Matt’s insights. d/b/a Drug Channels Institute.

Pharmaceuticals 85

Pharmaceuticals Drugs 85

Drug Channels

FEBRUARY 2, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She highlights how GoodRx’s integrated pharma copay cards help to improve medication access, therapy adherence, and overall health outcomes. Read on for Divya’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Therapies 80

Therapies Marketing Research Drugs 80

Drug Channels

JANUARY 19, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. I also offer some thoughts on non-medical switching and what we still don’t know about how exclusions affect patients. Let me know what you think by commenting below or on social media. d/b/a Drug Channels Institute. This Feed is for personal non-commercial use only.

Biosimilars 95

Biosimilars Pharmacy Drugs Production 95

Drug Channels

JANUARY 12, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Learn more about EVERSANA’s solutions from this complimentary whitepaper: Repairing the Patient Journey: How Pharma Can Fix the Obvious–and Not So Obvious–Breaking Points of Nonadherence. Read on for the authors’ insights. All rights reserved.

Therapies 81

Therapies Drugs 81

Drug Channels

SEPTEMBER 16, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. He also describes the circumstances where each solution provides the greatest value. To learn more, download AssistRx’s free eBook: Specialty Drug Patient Support Programs: 2022 Progress Report. Read on for Edward’s insights. d/b/a Drug Channels Institute.

Drugs 86

Drugs 86

Drug Channels

FEBRUARY 16, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Gavin’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Drugs 80

Drugs 80

Drug Channels

FEBRUARY 1, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Demonizing pharmaceuticals as a driver of U.S. healthcare spending growth is simply inaccurate. Sadly, our politicians and journalists will probably continue to ignore the facts in favor of their opinions. d/b/a Drug Channels Institute.

Hospitals 96

Hospitals Drugs Pharmaceuticals 96

Drug Channels

JANUARY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. I also highlight recent research that raises troubling questions about the patient impact of these ever-growing exclusion lists. As always, I welcome your comments below or on social media. All rights reserved.

Biosimilars 89

Biosimilars Pharmacy Production Drugs 89

Drug Channels

DECEMBER 9, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. They explain why the reported CEO total compensation numbers are deceiving. Access the full findings from AIS’ Healthcare Executive Compensation Survey here. Read on for Leslie’s and Jinghong’s insights. d/b/a Drug Channels Institute.

Packaging 87

Packaging Marketing Drugs 87

Drug Channels

JANUARY 10, 2023

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. I also note some troubling research on the patient impact of exclusions—although much remains unknown. As always, I welcome your comments below or on social media. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Biosimilars 93

Biosimilars Pharmacy Drugs Production 93

Drug Channels

MARCH 8, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To request an analysis of your copay savings program and learn more about Paysign’s patient affordability solutions, contact affordability@paysign.com or visit paysign.com/rx. Read on for Logan’s insights. All rights reserved.

Drugs 76

Drugs 76

Drug Channels

MAY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. They discuss five ways manufacturers can prevent these barriers from affecting patients. To learn more about navigating the complexities of market access, contact MMIT and its sister company, The Dedham Group. Read on for their insights.

Therapies 79

Therapies Marketing Drugs 79

Drug Channels

MARCH 15, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He shares data from a Cardinal Health survey of biopharmaceutical companies and offers four factors to consider when evaluating your patient support program. Read on for Josh’s insights. All rights reserved.

Drugs 78

Drugs 78

Drug Channels

MARCH 28, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. I also note some troubling research on the patient impact of exclusions—although much remains unknown. As always, I welcome your comments below or on social media. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Biosimilars 96

Biosimilars Pharmacy Drugs Production 96